Sirona Dental Systems — Q1 2013 Earnings Presentation
18 slides from Sirona Dental Systems's earnings presentation, Feb 8, 2013
Slide 1: Sirona – The Dental Company
Sirona – The Dental Company First Quarter 2013 Earnings Presentation February 8, 2013
Slide 2: Safe Harbor Statement / Additional Information
First Quarter 2013 Earnings Presentation Safe Harbor Statement / Additional Information This conference call contains forward-looking information about Sirona Dental Systems, Inc.’s financial results, guidance and estimates, business prospects, and products and services that involve substantial risk
Slide 3: Performance Summary
First Quarter 2013 Performance Summary 1Q13 constant currency revenue growth of 8.6%, with: CAD/CAM up 16.5%, cc Treatment Centers up 8.4%, cc Imaging up 4.9%, cc Instruments down 2.1%, cc Strong revenue growth despite a tough comparable and manufacturing constraints. Last year’s Q1 Sirona grew 10.2
Slide 4: Overview
First Quarter 2013 Earnings Presentation Overview Revenue U.S. sales were exceptionally strong, up 29.0%, (US$ in millions) positively impacted by our expanded exclusivity agreement with Patterson, strong demand for our CAD/CAM and Imaging products and the anticipated implementation of the Medical D
Slide 5: CAD/CAM Segment
First Quarter 2013 Earnings Presentation CAD/CAM Segment CAD/CAM Revenue Segment Gross Profit (US$ in millions) (US$ in millions) Revenue Growth Segment Gross Profit Margin Reported +13.5% 1Q12 70.9% Currency + 3.0% 1Q13 70.7% Constant Currency +16.5% Change -20 bps Page 5
Slide 6: CAD/CAM Segment: Record segment revenues of $95.6 million
First Quarter 2013 Earnings Presentation CAD/CAM Segment Record segment revenues of $95.6 million, up 13.5%, or up 16.5% cc. Omnicam launch generating significant order intake, but manufacturing constraints led to prioritization and impacted Q1 results, especially internationally. CAD/CAM segment gr
Slide 7: Imaging Segment
First Quarter 2013 Earnings Presentation Imaging Segment Imaging Revenue Segment Gross Profit (US$ in millions) (US$ in millions) Revenue Growth Segment Gross Profit Margin Reported +2.7% 1Q12 57.3% Currency +2.2% 1Q13 60.2% Constant Currency +4.9% Change +290 bps Page 7
Slide 8: Imaging Segment: Record revenues of $97.0 million
First Quarter 2013 Earnings Presentation Imaging Segment Record revenues of $97.0 million, up 2.7%, but up 4.9% cc despite a very challenging comparable. Last year’s Q1 Imaging grew ~24% cc. Sales were particularly strong in the U.S. Successful launch of Schick 33 Gross profit margin improved 290 bp
Slide 9: Treatment Centers
First Quarter 2013 Earnings Presentation Treatment Centers Treatment Center Revenue Segment Gross Profit (US$ in millions) (US$ in millions) Revenue Growth Segment Gross Profit Margin Reported +4.3% 1Q12 40.1% Currency +4.1% 1Q13 39.6% Constant currency +8.4% Change -50 bps Page 9
Slide 10: Treatment Centers: Record revenues of $53.4 million
First Quarter 2013 Earnings Presentation Treatment Centers Record revenues of $53.4 million, up 4.3%, or up 8.4% cc. Growth was strong across most geographies. Above market growth resulting in continued market share gains. Robust performance of the comfort and standard product lines. Slight gross pr
Slide 11: Instruments
First Quarter 2013 Earnings Presentation Instruments Instruments Revenue Segment Gross Profit (US$ in millions) (US$ in millions) Revenue Growth Segment Gross Profit Margin Reported -5.8% 1Q12 47.8% Currency +3.7% 1Q13 46.2% Constant Currency -2.1% Change -160 bps Page 11
Slide 12: Instruments: Revenues of $26.4 million
First Quarter 2013 Earnings Presentation Instruments Revenues of $26.4 million, down 5.8%, or down 2.1% cc. Challenging comparison to the prior year where instruments grew 8.4% cc. Margin contraction mainly due to product mix. Page 12
Slide 13: Operating Performance
First Quarter 2013 Earnings Presentation Operating Performance 1Q13 1Q12 % chg. Revenue $ 272,404 $ 258,116 5.5% Cost of sales 120,533 119,333 1.0% Gross profit 151,871 138,783 9.4% Selling, general and administrative expense 85,783 73,646 16.5% Research and development 14,095 13,286 6.1% Other oper
Slide 14: Guidance
First Quarter 2013 Earnings Presentation Guidance Guidance Page 14
Slide 15: Conclusion
First Quarter 2013 Earnings Presentation Conclusion Solid business momentum continues. Commitment to innovation Comprehensive, market leading product portfolio Global sales and service infrastructure Geographic diversification Best-in-class distribution network Outstanding team effort Strong financi
Slide 16: Questions and Answers
First Quarter 2013 Earnings Presentation Questions and Answers Q&A Page 16
Slide 17: Reconciliation of GAAP EPS to Non-GAAP Adjusted EPS
Reconciliation of GAAP EPS to Non-GAAP Adjusted EPS CURRENT QUARTER GAAP Reconciliation to Non-GAAP Three months ended December 31, 2012 Per Diluted Pre Tax Tax Impact* After Tax S hare $'000s, except per share amount GAAP net income attributable to S irona Dental S ystems, Inc. shareholders $ 38,30
Slide 18: Non-GAAP Measures Disclosure
Non-GAAP Measures Disclosure To supplement our consolidated financial statements and our business outlook, we use the following non-GAAP financial measures: (i) non-GAAP adjusted net income, and (ii) non-GAAP adjusted earnings per diluted share, which exclude, as applicable, amortization and depreci
Sirona Dental Systems — Q1 2013 Earnings Presentation on 6ix